The efficacy and safety of ofloxacin in the treatment of 30 patients with acute exacerbations of chronic bronchitis were evaluated in an open, noncomparative trial. Patients received ofloxacin 400 mg in a single daily dose for 10 days. On day 11, 86.7% of the patients were cured and 13.3% ...
The efficacy and safety of ofloxacin in the treatment of 30 patients with acute exacerbations of chronic bronchitis were evaluated in an open, noncomparative trial. Patients received ofloxacin 400 mg in a single daily dose for 10 days. On day 11, 86.7% of the patients were cured and 13.3% ...
Interventions Randomization 1:1 to sparfloxacin, 400 mg on day 1, then 200 mg once daily, or ofloxacin, 400 mg twice daily, with matching comparator placebos, given concurrently for 10 consecutive days. Results The primary efficacy parameter was overall response in the bacteriologically evaluable ...
1477943 Octisalate辛水杨酯 400mg (Octyl Salicylate) CAS:118-60-51478083 R-Ofloxacin 25mg ((R)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) CAS:100986-86-51478108 Ofloxacin氧氟沙星 200mg CAS:82419-36-1...
1993. Tissue and serum concentrations of ofloxacin in the ear region following a single daily oral dose of 400 mg. Infection 21:63-5.Tolsdorff P. Tissue and serum concentrations of ofloxacin in the ear region following a single daily oral dose of 400mg. Infection 1993 Jan-Feb; 21(1): ...
Methods: Women from hospitals throughout 13 countries received a 14 day course of either oral moxifloxacin, 400 mg once daily (n = 384), or oral ofloxacin, 400 mg twice daily plus oral metronidazole, 500 mg twice daily (n = 365). Results: Of the 741 patients in the intent ...
Ten patients (mean age 63 years) undergoing alloarthroplastic hip joint replacement received 400 mg ofloxacin orally before anaesthesia. Venous blood samples were obtained before administration of the drug and then at intervals of up to 24 h. Bone samples were taken from femoral head and femoral ...
Aim:To evaluate the pharmacokinetic interactions between theophylline and antofloxacin in vivo and in vitro.Methods:A randomized,5-day treatment and 3-way crossover design was documented in 12 healthy subjects.The subjects were orally administered with antofloxacin (400 mg on d 1 and 200 mg on ...
This was a prospective, multicenter, double-blind, double-dummy, randomized, controlled, parallel-group, Phase III, non-inferiority clinical trial designed to compare oral zabofloxacin (367 mg once daily for 5 days) with moxifloxacin (400 mg once daily for 7 days) for the treatment of ...
Methods: Women from hospitals throughout 13 countries received a 14 day course of either oral moxifloxacin, 400 mg once daily (n = 384), or oral ofloxacin, 400 mg twice daily plus oral metronidazole, 500 mg twice daily (n = 365). Results: Of the 741 patients in the intent ...